CA2428595A1 - Staphylococcus aureus protein staau_r2, gene encoding it and uses thereof - Google Patents

Staphylococcus aureus protein staau_r2, gene encoding it and uses thereof Download PDF

Info

Publication number
CA2428595A1
CA2428595A1 CA002428595A CA2428595A CA2428595A1 CA 2428595 A1 CA2428595 A1 CA 2428595A1 CA 002428595 A CA002428595 A CA 002428595A CA 2428595 A CA2428595 A CA 2428595A CA 2428595 A1 CA2428595 A1 CA 2428595A1
Authority
CA
Canada
Prior art keywords
polypeptide
staau
seq
fragment
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002428595A
Other languages
English (en)
French (fr)
Inventor
Michael DuBow
Dominique Bergeron
Jerry Pelletier
Philippe Gros
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Targanta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/727,892 external-priority patent/US20040091856A1/en
Application filed by Targanta Therapeutics Inc filed Critical Targanta Therapeutics Inc
Publication of CA2428595A1 publication Critical patent/CA2428595A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
CA002428595A 2000-11-30 2001-11-30 Staphylococcus aureus protein staau_r2, gene encoding it and uses thereof Abandoned CA2428595A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/727,892 2000-12-01
US09/727,892 US20040091856A1 (en) 1999-12-01 2000-12-01 DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides
US88556101A 2001-06-20 2001-06-20
US09/885,561 2001-06-20
PCT/CA2001/001754 WO2002044718A2 (en) 2000-11-30 2001-11-30 S.aureus protein staau r2, gene encoding it and uses thereof

Publications (1)

Publication Number Publication Date
CA2428595A1 true CA2428595A1 (en) 2002-06-06

Family

ID=27111604

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002428595A Abandoned CA2428595A1 (en) 2000-11-30 2001-11-30 Staphylococcus aureus protein staau_r2, gene encoding it and uses thereof

Country Status (5)

Country Link
EP (1) EP1340079A2 (https=)
JP (1) JP2004522945A (https=)
AU (2) AU2042202A (https=)
CA (1) CA2428595A1 (https=)
WO (1) WO2002044718A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116908265B (zh) * 2023-09-11 2023-12-12 常州先趋医疗科技有限公司 检测核酸lamp扩增产物电化学生物传感器的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU774841B2 (en) * 1998-12-03 2004-07-08 Targanta Therapeutics Inc. Development of novel anti-microbial agents based on bacteriophage genomics
EP1242611A4 (en) * 1999-12-22 2004-08-11 Phagetech Inc COMPOSITIONS AND METHODS USING AN ESSENTIAL STAPHYLOCOCUS AUREUS GENE AND ITS ENCODED PROTEIN

Also Published As

Publication number Publication date
JP2004522945A (ja) 2004-07-29
WO2002044718A2 (en) 2002-06-06
AU2002220422B2 (en) 2007-06-28
AU2002220422B9 (en) 2002-06-11
AU2042202A (en) 2002-06-11
WO2002044718A3 (en) 2002-12-12
EP1340079A2 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
US6660520B2 (en) Nrde
EP0899334A2 (en) FtsZ polypeptides from Streptococcus pneumoniae
CA2433386C (en) Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r9
US6228584B1 (en) DexB
AU2002220422B2 (en) S.aureus protein STAAU R2, gene encoding it and uses thereof
US7101969B1 (en) Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein
AU2002224692B2 (en) Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein STAAU_R4
US20040137516A1 (en) DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides
AU2002220422A1 (en) S.aureus protein STAAU R2, gene encoding it and uses thereof
US6361965B1 (en) YfiI pseudouridine synthase
US6331411B1 (en) TopA
WO2000029547A1 (en) YfiI PSEUDOURIDINE SYNTHASE
CA2396674C (en) Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein
US6194170B1 (en) MurF of Streptococcus pneumoniae
US6432703B1 (en) RATC from Streptococcus pneumoniae
US6222014B1 (en) NrdE of staphylococcus aureus
US6261802B1 (en) Ups (ugc)
EP0890644A2 (en) MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase
EP0905247A2 (en) MurF polynucleotides and polypeptides from Staphylococcus
EP0892063A2 (en) Histidine kinase
EP1074623A1 (en) ABC transporter
EP1038962A1 (en) Peptidoglycan biosynthetic gene murF from Streptococcus pneumoniae

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued